文献リスト

1）http://connect.asmbs.org/index.php?s= 20295&item=122422

2）Lew EA, Garfinkel L. Variations in mortality by weight among 750,000 men and women. J Chronic Dis. 1979; 32: 563-76

3）Stevens J, et al. The effect of age on the association between body-mass index and mortality. N Engl J Med. 1998; 338: 1-7

4）Perri MG, Fuller PR. Success and failure in the treatment of obesity: where do we go from here? Med Exerc Nutr Health. 1995; 4: 255-72

5）National Task Force on the Prevention and Treatment of Obesity: Very low calorie diets. JAMA. 1993; 270: 967-74

6）Powers PS. Conservative treatments for morbid obesity, in Surgery for the morbidly obese patient, M. Deitel, Editor. Philadelphia: Lea and Febiger; 1989. p. 27-37

7）Rand CS, Macgregor AM, Hankins GC. Eating behavior after gastric bypass surgery for obesity. South Med J. 1987; 80: 961-4

8）Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013; 23: 427-36

9）Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007; 357: 741-52

10）Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004; 240: 416-23

11）Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007; 357: 753-61

12）Busetto L, Mirabelli D, Petroni ML, et al. Comparative long-term mortality after laparoscopic adjustable gastric banding versus nonsurgical controls. Surg Obes Relat Dis. 2007; 3: 496-502

13）Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004; 292: 1724-37

14）Brethauer SA, Hammel JP, Schauer PR. Systematic review of sleeve gastrectomy as staging and primary bariatric procedure. Surg Obes Relat Dis. 2009; 5: 469-75

15）Dixon JB, OʼBrien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008; 299: 316-23

16）Schauer PR , Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012; 366: 1567-76

17）Kashyap SR, Bhatt DL, Wolski K, et al. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: Analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care. 2013; 36: 2175-82

18）Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012; 366: 1577-85

19）Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA. 2013; 309: 2240-9

20）Rubino F. Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care. 2008; 31 Suppl 2: S290-6

21）Rubino F, Shukla A, Pomp A, et al. Bariatric, Metabolic, and Diabetes Surgery: Whatʼs in a Name? Ann Surg. 2013 Jan 10. [Epub ahead of print]

22）Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995; 222: 339-50

23）Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes. A new perspective for an old disease. Ann Surg. 2004; 239: 1-11

24）Kindel TL, Yoder SM, Seelt RJ, et al. Duodenal-jejunal exclusion improves glucose tolerance in the diabetic, Goto-Kakizaki rat by a GLP-1 receptor-mediated mechanism. J Gastrointest Surg. 2009; 13: 1762-72

25）Laferrere B, Teixeira J, McGinty J, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab. 2008; 93: 2479-85

26）Zhang H, DiBaise JK, Zuccolo A, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A. 2009; 103: 10011-6

27）Troy S, Soty M, Ribeiro L, et al. Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metab. 2008; 8: 201-11

28）Gastrointestinal Surgery for Severe Obesity. NIH Consens Statement Online 1991 Mar 25-27; 9(1): 1-20

29）Lee WJ, Wang W. Bariatric surgery: Asia-Pacific perspective. Obes Surg. 2005; 15: 751-7

30）内視鏡および内視鏡外科肥満治療法に関する三学会合同委員会合意事項．http://www.jses.or.jp/member/regulation_goui.html

31）肥満症治療学会．日本における高度肥満症に対する安全で卓越した外科治療のためのステートメント2010. http://plaza.umin.ne.jp/~jsto/gakujyutsu/updata/statement_2010.pdf

32）Rubino F, Kaplan LM, Schauer PR, et al. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg. 2010; 251: 399-405

33）American Diabetes Association: Standard of Medical Care in Diabetes 2009. Diabetes Care. 2009; 32: supplement 1

34）Lakdawala M, Bhasker A. Asian Consensus Meeting on Metabolic Surgery (ACMOMS). Report: Asian Consensus Meeting on Metabolic Surgery. Recommendations for the use of Bariatric and Gastrointestinal Metabolic Surgery for Treatment of Obesity and Type II Diabetes Mellitus in the Asian Population: August 9th and 10th, 2008, Trivandrum, India. Obes Surg. 2010; 20: 929-36

35）Kasama K, Mui W, Lee WJ, et al. IFSO-APC consensus statements 2011. Obes Surg. 2012; 22: 677-84

36）Dixon JB, Zimmet P, Alberti KG, et al. Bariatric surgery: an IDF statement for obese Type2 diabetes. Diabet Med. 2011; 28: 628-42

37）WHO expert consultation. Appropriate body-mass index for Asian populations and its impli­cations for policy and intervention strategies. Lancet. 2004; 363: 157-63

38）日本肥満症治療学会肥満外科治療ガイドライン策定委員会．日本における高度肥満症に対する安全で卓越した外科治療のためのガイドライン（2013年版）．http://plaza.umin.ne.jp/~jsto/gakujyutsu/updata/surgery_guideline_2013.pdf

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp